Cholinergic Regulation of Orexin/Hypocretin Neurons Through M3 Muscarinic Receptor in Mice

  • Ohno Kousaku
    Department of Pharmacology, Institute of Basic Medical Sciences, University of Tsukuba, Japan
  • Hondo Mari
    Department of Pharmacology, Institute of Basic Medical Sciences, University of Tsukuba, Japan
  • Sakurai Takeshi
    Department of Molecular Neuroscience and Integrative Physiology, Graduate School of Medical Science, Kanazawa University, Japan

この論文をさがす

抄録

The cholinergic system plays an important role in regulation of arousal and REM sleep. In the present study, we showed that a muscarinic receptor agonist, carbachol (CCh), activates almost 20% of orexin-producing neurons (orexin neurons), which play a critical role in maintenance of arousal. We also found that a very small population of orexin neurons (1%) was inhibited by CCh. Muscarinic receptor antagonists inhibited the CCh-induced activation of orexin neurons in a dose-dependent manner. The M3-selective muscarinic receptor antagonist 4-diphenylacetoxy-N-methyl-piperidine methiodide (4-DAMP) affected the response at a significantly lower concentration compared with the M1-selective muscarinic antagonist pirenzepine. IC50 of 4-DAMP and pirenzepine was 0.30 ± 0.15 and 59.9 ± 18.6 nM, respectively. The CCh-induced inward current was attenuated by the nonselective cation channel blocker SKF96365. These results indicate that CCh activates 20% of orexin neurons through the M3 muscarinic receptor and subsequent activation of nonselective cation channels.<br>

収録刊行物

参考文献 (69)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ